6 reports of this reaction
2.7% of all PASSIFLORA INCARNATA FLOWERING TOP reports
#7 most reported adverse reaction
HEPATIC FAILURE is the #7 most commonly reported adverse reaction for PASSIFLORA INCARNATA FLOWERING TOP, manufactured by Boiron. There are 6 FDA adverse event reports linking PASSIFLORA INCARNATA FLOWERING TOP to HEPATIC FAILURE. This represents approximately 2.7% of all 226 adverse event reports for this drug.
Patients taking PASSIFLORA INCARNATA FLOWERING TOP who experience hepatic failure should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
HEPATIC FAILURE is a less commonly reported adverse event for PASSIFLORA INCARNATA FLOWERING TOP, but still significant enough to appear in the safety profile.
In addition to hepatic failure, the following adverse reactions have been reported for PASSIFLORA INCARNATA FLOWERING TOP:
The following drugs have also been linked to hepatic failure in FDA adverse event reports:
HEPATIC FAILURE has been reported as an adverse event in 6 FDA reports for PASSIFLORA INCARNATA FLOWERING TOP. This does not prove causation, but indicates an association observed in post-market surveillance data.
HEPATIC FAILURE accounts for approximately 2.7% of all adverse event reports for PASSIFLORA INCARNATA FLOWERING TOP, making it a notable side effect.
If you experience hepatic failure while taking PASSIFLORA INCARNATA FLOWERING TOP, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.